Grant: Collaborative Research and Development Grants
University of Calgary
$30,000.00
Rapid sample preparation of pharmaceutical tablets using sub-critical fluid extraction methods
FY 2010-11
Summary
The drug development process is of great concern to the pharmaceutical industry and of great benefit to
Canadians and others worldwide. Before a potential drug can make it to the marketplace, it must first undergo
an enormous amount of testing in order to assess the impact of various things on the effectiveness of the drug.
These include factors such as the tablet form, the drug concentration, and the storage conditions to name only a
few. For each of these tests, the pharmaceutical tablet must be analyzed for its contents in order to know if any
effects are noted on the composition. Currently, the actual analysis of such tablet contents is relatively rapid.
However, preparing the tablet contents for such an analysis is quite lengthy and presents a major delay in
analytical laboratory efforts to support the drug development process. As a result, increasing the speed of such
sample preparation methods can directly increase the speed of the drug development process. This research
looks at novel methods of pharmaceutical sample preparation that employ sub-critical fluids. Such fluids are
simply solvents held at elevated pressures and temperatures. However, under these conditions, they are much
more efficient at dissolving substances and isolating them for analysis. Relatively little is known about their
effectiveness in pharmaceutical tablet extractions. This work will explore the use of sub-critical organic
solvents, sub-critical water, and lower temperature organic solvent/liquid carbon dioxide mixtures in the
removal of pharmaceuticals from tablet contents for analysis. The work will provide a comprehensive guide to
the effectiveness and usage of such extraction methods in this area and will advance current knowledge
regarding the capabilities of these techniques. It is anticipated that significant improvements will be realized in
the amount of time, solvent, and handling procedures that are required in preparing pharmaceutical tablets for
analysis relative to existing methods. In doing so, this will increase drug development speed and reduce
hazardous organic solvent usage, both of which can improve the lives of Canadians.
Program
Collaborative Research and Development Grants
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
369075-2008
Name nom
Thurbide, Kevin
Department département
Chemistry
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
30000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Partie
3
Nb partie
3
Application title
Rapid sample preparation of pharmaceutical tablets using sub-critical fluid extraction methods
Keyword
NSERC
Application summary
The drug development process is of great concern to the pharmaceutical industry and of great benefit to
Canadians and others worldwide. Before a potential drug can make it to the marketplace, it must first undergo
an enormous amount of testing in order to assess the impact of various things on the effectiveness of the drug.
These include factors such as the tablet form, the drug concentration, and the storage conditions to name only a
few. For each of these tests, the pharmaceutical tablet must be analyzed for its contents in order to know if any
effects are noted on the composition. Currently, the actual analysis of such tablet contents is relatively rapid.
However, preparing the tablet contents for such an analysis is quite lengthy and presents a major delay in
analytical laboratory efforts to support the drug development process. As a result, increasing the speed of such
sample preparation methods can directly increase the speed of the drug development process. This research
looks at novel methods of pharmaceutical sample preparation that employ sub-critical fluids. Such fluids are
simply solvents held at elevated pressures and temperatures. However, under these conditions, they are much
more efficient at dissolving substances and isolating them for analysis. Relatively little is known about their
effectiveness in pharmaceutical tablet extractions. This work will explore the use of sub-critical organic
solvents, sub-critical water, and lower temperature organic solvent/liquid carbon dioxide mixtures in the
removal of pharmaceuticals from tablet contents for analysis. The work will provide a comprehensive guide to
the effectiveness and usage of such extraction methods in this area and will advance current knowledge
regarding the capabilities of these techniques. It is anticipated that significant improvements will be realized in
the amount of time, solvent, and handling procedures that are required in preparing pharmaceutical tablets for
analysis relative to existing methods. In doing so, this will increase drug development speed and reduce
hazardous organic solvent usage, both of which can improve the lives of Canadians.